Nala Genetics, a Singapore-based company, showcased their genetic testing kits and software at MEDICA 2023. Their first product, Nala Clinical Decision Support, combines polygenic, monogenic, and clinical risk scores to report on pharmacogenomics, neurogenetics, and risk prediction for various conditions. They are looking to partner with hospitals and labs worldwide to implement personalized medicine programs based on PCR or sequencing data. For more information, visit www.nalagenetics.com or contact [email protected].Generated by OpenAI
